Koninklijke Philips (PHG) Cash from Investing Activities (2009 - 2026)

Koninklijke Philips' (PHG) quarterly Cash from Investing Activities came in at -$475.3 million in Q1 2026, down 187.82% year-on-year from $541.2 million in Q1 2025, and up 44.59% quarter-over-quarter from -$857.9 million in Q4 2025.

Koninklijke Philips (PHG) Cash from Investing Activities (2009 - 2026) Analysis & Trends

Koninklijke Philips' Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$475.3 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 187.82% year-over-year to -$475.3 million in Q1 2026; TTM through Mar 2026 was -$2.2 billion, a 33.6% decrease from a year earlier, with the FY2025 full-year figure at -$857.9 million, down 40.11% from the prior year.
  • Cash from Investing Activities climbed to -$475.3 million in Q1 2026 per PHG's latest filing, from -$857.9 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$165.1 million in Q1 2025 and bottomed at -$1.5 billion in Q4 2022.
  • The 5-year median for Cash from Investing Activities is -$520.6 million (2024), against an average of -$584.7 million.
  • Across the five-year window, Cash from Investing Activities surged 75.77% in 2022 and slumped 187.82% in 2026, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$1.5 billion in 2022, then soared by 54.89% to -$684.3 million in 2023, then grew by 10.52% to -$612.3 million in 2024, then slumped by 40.11% to -$857.9 million in 2025, then surged by 44.59% to -$475.3 million in 2026.
  • Per Business Quant, the three latest PHG Cash from Investing Activities figures stand at -$475.3 million (Q1 2026), -$857.9 million (Q4 2025), and -$632.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 181.51 Bn 174.22 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.20 Bn 125.32 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.69 Bn 98.47 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 68.05 Bn 66.59 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 47.52 Bn 43.85 Bn 1.29 Bn -92.80 Mn
6 GE HealthCare Technologies 28.46 Bn 26.17 Bn 1.98 Bn -2.50 Bn
7 Dexcom 28.25 Bn 27.13 Bn 750.30 Mn -298.50 Mn
8 Smith & Nephew 26.73 Bn 26.15 Bn - -
9 Koninklijke Philips 25.31 Bn 22.19 Bn 2.07 Bn -475.32 Mn
10 Steris 21.43 Bn 20.99 Bn 697.10 Mn -217.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -475.32 Mn
Mar 31, 2026 -475.32 Mn
Dec 31, 2025 -857.90 Mn
Dec 31, 2025 -857.90 Mn
Sep 30, 2025 -632.46 Mn
Sep 30, 2025 -632.46 Mn
Jun 30, 2025 -254.69 Mn
Jun 30, 2025 -254.69 Mn
Mar 31, 2025 -165.15 Mn
Mar 31, 2025 -165.15 Mn
Dec 31, 2024 -612.31 Mn
Dec 31, 2024 -612.31 Mn
Sep 30, 2024 -520.56 Mn
Sep 30, 2024 -520.56 Mn
Jun 30, 2024 -363.99 Mn
Jun 30, 2024 -363.99 Mn
Mar 31, 2024 -190.11 Mn
Mar 31, 2024 -190.11 Mn
Dec 31, 2023 -684.30 Mn
Dec 31, 2023 -684.30 Mn